These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33780499)

  • 1. What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment.
    van Egmond S; de Vries E; Hollestein L; Bastiaens M; de Roos KP; Kuijpers D; Steyerberg E; Wakkee M; Mosterd K; Nijsten T; de Bekker-Grob EW
    PLoS One; 2021; 16(3):e0249298. PubMed ID: 33780499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing current low-value follow-up care after basal cell carcinoma and suggested strategies for de-adoption: a qualitative study.
    van Egmond S; Wakkee M; van Rengen A; Bastiaens MT; Nijsten T; Lugtenberg M
    Br J Dermatol; 2019 Jun; 180(6):1420-1429. PubMed ID: 30597525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial.
    Tinelli M; Ozolins M; Bath-Hextall F; Williams HC
    BMC Dermatol; 2012 Oct; 12():19. PubMed ID: 23035730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care.
    van Egmond S; van Vliet ED; Wakkee M; Hollestein LM; Pouwels XGLV; Koffijberg H; Misirli Y; Bakkum RSLA; Bastiaens MT; Kukutsch NA; Oosting AJ; Plasmeijer EI; van Rengen A; de Roos KP; Nijsten TEC; de Vries E; de Bekker-Grob EW
    PLoS One; 2022; 17(1):e0260978. PubMed ID: 35073333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study.
    van Egmond S; Wakkee M; Droger M; Bastiaens MT; van Rengen A; de Roos KP; Nijsten T; Lugtenberg M
    Br J Dermatol; 2019 Jan; 180(1):122-129. PubMed ID: 29927480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey among patients with basal cell carcinoma in The Netherlands.
    Gerritsen MJ; De Rie MA; Beljaards RC; Thissen MR; Kuipers MV
    J Dermatolog Treat; 2009; 20(4):213-8. PubMed ID: 19125362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of basal cell carcinoma in Scandinavia: evidence or eminence based?
    Helsing P; Gjersvik P; Tarstedt M
    Int J Dermatol; 2015 Sep; 54(9):1030-3. PubMed ID: 25660368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Preferences for Treatment of Basal Cell Carcinoma: Importance of Cure and Cosmetic Outcome.
    Martin I; Schaarschmidt ML; Glocker A; Herr R; Schmieder A; Goerdt S; Peitsch WK
    Acta Derm Venereol; 2016 Mar; 96(3):355-60. PubMed ID: 26537095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trading patients' choice in providers for quality of maternity care? A discrete choice experiment amongst pregnant women.
    Lambooij MS; Veldwijk J; van Gils PF; Suijkerbuijk AWM; Struijs JN
    PLoS One; 2020; 15(4):e0232098. PubMed ID: 32330182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists.
    Ashcroft DM; Seston E; Griffiths CE
    Br J Dermatol; 2006 Dec; 155(6):1236-41. PubMed ID: 17107395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Rate of Complete Excision of Basal Cell Carcinoma by Dermatologists, Plastic Surgeons and General Practitioners: A Large Cross-Sectional Study.
    Ramdas K; van Lee C; Beck S; Bindels P; Noordhoek Hegt V; Pardo L; Versnel S; Nijsten T; van den Bos R
    Dermatology; 2018; 234(3-4):86-91. PubMed ID: 30086541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
    Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
    Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eliciting Older Cancer Patients' Preferences for Follow-Up Care to Inform a Primary Healthcare Follow-Up Model in China: A Discrete Choice Experiment.
    Geng J; Li R; Wang X; Xu R; Liu J; Jiang H; Wang G; Hesketh T
    Patient; 2024 Sep; 17(5):589-601. PubMed ID: 38702574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up after treatment for breast cancer: one strategy fits all? An investigation of patient preferences using a discrete choice experiment.
    Kimman ML; Dellaert BG; Boersma LJ; Lambin P; Dirksen CD
    Acta Oncol; 2010 Apr; 49(3):328-37. PubMed ID: 20148645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' Preferences for Artificial Intelligence Applications Versus Clinicians in Disease Diagnosis During the SARS-CoV-2 Pandemic in China: Discrete Choice Experiment.
    Liu T; Tsang W; Huang F; Lau OY; Chen Y; Sheng J; Guo Y; Akinwunmi B; Zhang CJ; Ming WK
    J Med Internet Res; 2021 Feb; 23(2):e22841. PubMed ID: 33493130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences heterogeneity of health care utilization of community residents in China: a stated preference discrete choice experiment.
    Jiang MZ; Fu Q; Xiong JY; Li XL; Jia EP; Peng YY; Shen X
    BMC Health Serv Res; 2020 May; 20(1):430. PubMed ID: 32423447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of basal cell carcinoma patients by dermatologists in Netherland].
    Thissen MR; Neumann HA; Berretty PJ; Ideler AH
    Ned Tijdschr Geneeskd; 1998 Jul; 142(27):1563-7. PubMed ID: 9763832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal cell carcinoma follow-up practices by dermatologists: a national survey.
    Bower CP; Lear JT; de Berker DA
    Br J Dermatol; 2001 Dec; 145(6):949-56. PubMed ID: 11899149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment.
    Essers BAB; Arits AH; Hendriks MR; Mosterd K; Kelleners-Smeets NW
    Br J Dermatol; 2018 Jan; 178(1):e26-e27. PubMed ID: 28667739
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing the public's preference for surgical treatment of primary basal cell carcinoma: a discrete-choice experiment in the south of the Netherlands.
    Essers BA; Dirksen CD; Prins MH; Neumann HA
    Dermatol Surg; 2010 Dec; 36(12):1950-5. PubMed ID: 21070461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.